Baird's CMC | A Unique Global Communications Management Consultancy

Global Health Discourse 2023

Tel: +44 (0) 1495 828300
Email: team@bairdscmc.com
  • E-mail
  • LinkedIn
  • Twitter
Menu
  • Home
    • Sexual and Reproductive Health
    • Stakeholder Mapping & Strategy
    • New Services
    • Qualitative & Policy
    • Communications and Management Consultancy
    • Close
  • About us
    • Privacy Policy
    • Our specialist areas
    • Case studies
      • EDCTP sub-Saharan Africa policy research
      • Emerging Democracies and Green Issues
      • Gauging Attitudes Toward an HIV Vaccine
      • Increasing Immunization Coverage in Central India
      • Close
    • Close
  • Network
    • Network map
    • Associates
      • Michael Acott
      • Ashoek Adhikari
      • Francois Baird
      • Gil Bashe
      • Alain Bernal
      • Gerhard Butschi
      • Steve Bowers
      • Mark Chataway
      • Lenore Cooney
      • Paul Dillon
      • Marta Dourado
      • Martina Dörmann
      • Dirk Van Eeden
      • Alexandra Fullem
      • Frederick Fussi
      • Ingrid Gavshon MBA
      • Denise Gee
      • Sabrina Gomersall
      • Denise Gray-Felder
      • Bert Griesel
      • Aman Gupta
      • Themba Hlengani
      • Darren Jones
      • Danie Kok
      • Andrzej Kropiwnicki
      • Angelle Kwemo
      • Nikolay Kudryashov
      • Mari Lee
      • Simba Makoni
      • Steve Mallach
      • Terry Mandel
      • Matshidiso Masire
      • Valeria McFarren
      • Hugh McKinney
      • Chris Opperman
      • Jenny Ousbey
      • Jens Pedersen
      • Ken Rabin
      • Mark Rittenberg
      • Simon Russell
      • Jacob Sesinyi
      • Roudie Shafie
      • Melinda Shaw
      • Cormac Smith
      • James Snodgrass
      • Hema Viswanathan
      • Mina Volovitch
      • Gillian Waddell
      • Joseph Makwata Wambia
      • Chris Ward
      • Gysbert J Wessels
      • Marion Zibelli
      • Close
    • Senior consultants
      • Simon Hardie
      • Close
    • Close
  • Services
    • New Services
      • Media Training
      • Presentation Skills
      • Staff Engagement
      • Reputation Management
      • Close
    • Services
      • Communications counsel
      • New media strategy
      • Advocacy and coalition building
      • Crisis management
      • Market research
      • Strategic planning
      • Staff training and development
      • Risk management and mitigation
      • Close
    • Close
  • Sectors
    • Vaccine Hesitancy
    • Pharma in top 15 markets
    • Pharma in emerging markets
    • Pharma in underdeveloped markets
    • Pharma headquarters planning teams on market assessment
    • Global Development: Health Issues
    • Global Development: Environmental Issues
    • Health equity and access to care
    • Reproductive health and population
    • Vaccines
    • International Donors
    • Government Relations
    • Political Consulting
    • Telecom Sector
    • Financial Services
    • Close
  • News
  • ShopTalk
  • Get in Touch

A Development Dilemma

“This one time, I was in a meeting of African health ministers, and they were being lectured by a group of very well-meaning Europeans and Americans (who, by the way, are very keen on lecturing Africans in general). Finally, the health minister of Cote-d’Ivoire (Ivory Coast) had had enough of this,” Mark chuckles, “so he stood up and said, ‘It might have escaped your notice but you stopped running this country 50 years ago.’ The American and European delegation was pretty quiet after that – I think they were a bit lost for words!”

“That’s an anecdote but that is the strain that underlies a lot of international development assistance. There’s the whole long-standing argument about who really does know best,” explains Mark. “The Americans are pretty overt about saying they know where they want their money spent. The Europeans try, at least on paper, to say that they want to support sovereign governments and what they want to do – but, in fact, of course they also interfere.”

This is indeed a fundamental question about development assistance: To what extent should the countries that provide the development assistance decide what the priorities are for that money? Mark emphasises that there are no simple answers to this very big question. “I think it’s undoubtedly true that in most developing countries, the poorest of the poor – who are the target of the development money in most cases – are not politically powerful. There are, of course, exceptions, but they’re not going to be the natural political constituency that has to be appeased. This is the case even in industrialised countries… The rich have been getting richer and the poor poorer even in the U.S.!” says Mark.

Mark thinks if western governments do want their money to be focused on the poorest of the poor, then they’re going to have to be fairly proactive about saying that’s what they’re giving the money for – and that will inevitably cause resentment. “By the way, even when the poorest of the poor are in control, it may not mean the donors are any happier with they where their money’s going. Just because the historically most disadvantaged are now in charge, it’s not a recipe for excellent government spending. I’m sure you can think of several examples,” Mark says with a wry smile, reminding us that the issue is not black and white, and that preconceived notions and assumptions simply don’t cut it when it comes to the dilemma of development assistance.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • More
  • Click to share on LinkedIn (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Related

Filed Under: ShopTalk Tagged With: Development

Contact Us

    Your Name (required)

    Your Email (required)

    Subject

    Your Message

    Please enter the letters below and press Send

    captcha

    Latest Blog Posts

    FRANCOIS BAIRD: America Will Need To Play The Long Game In Israel’s War On Terror

    An astonishing decline in child immunisation numbers in Africa amid the rage of COVID-19, yet another victim of the pandemic

    Global Elite are Bored with Health, Just When It’s Getting Really Exciting

    Copyright © 2023 All rights reserved. Sitemap